✦ LIBER ✦

IMO 1607 Clinical evaluation of a new oral ultrasound contrast agent

✍ Scribed by Barry B. Goldberg; Anna S. Lev-Toaff; Daniel A. Merton; Laurence Needleman; Nandkumar Rawool

Publisher: Elsevier Science
Year: 1997
Tongue: English
Weight: 121 KB
Volume: 23
Category: Article
ISSN: 0301-5629
DOI: 10.1016/s0301-5629(97)80449-8

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Phase I clinical evaluation of a new iro

Phase I clinical evaluation of a new iron oxide MR contrast agent

✍ Stuart J. McLachlan; Marie R. Morris; Maria A. Lucas; Ricardo A. Fisco; Michael 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 735 KB

## Abstract The safety and magnetic resonance (MR) imaging potential of BMS 180549, a new superparamagnetic iron oxide contrast agent, were evaluated in a phase I, open‐label, placebo‐controlled study involving 41 healthy subjects. No clinically significant postdose changes in physical examination

Clinical evaluation of indoramin, a new

Clinical evaluation of indoramin, a new antihypertensive agent

✍ P. J. Lewis; C. F. George; C. T. Dollery 📂 Article 📅 1973 🏛 Springer 🌐 English ⚖ 465 KB

Clinical evaluation of a new alkylating

Clinical evaluation of a new alkylating agent: Cytoxan (cyclophosphamide)

✍ Peter R. Coggins; Robert G. Ravdin; Sylvan H. Eisman 📂 Article 📅 1960 🏛 John Wiley and Sons 🌐 English ⚖ 514 KB

Clinical evaluation of a new combined or

Clinical evaluation of a new combined oral contraceptive desogrestrel-ethinylestradiol

✍ J. A. Yabur; M. Alvarado; V. Brito 📂 Article 📅 1989 🏛 Springer 🌐 English ⚖ 666 KB

Glipizide, a new oral antidiabetic agent

Glipizide, a new oral antidiabetic agent (report of a controlled clinical study in Sweden)

✍ A. Johannessen; S. E. Fagerberg 📂 Article 📅 1973 🏛 Springer 🌐 English ⚖ 867 KB

Preliminary clinical trial of gadodiamid

Preliminary clinical trial of gadodiamide injection: A new nonionic gadolinium contrast agent for MR imaging

✍ Gabriela D. Kaplan; Alex M. Aisen; S. Rao Aravapalli 📂 Article 📅 1991 🏛 John Wiley and Sons 🌐 English ⚖ 685 KB

The safety and efficacy of a newly developed intravenous formulation of the nonionic contrast agent gadolinium diethylenetriaminepentaacetic acid-bis(methylamide), formulated as gadodiamide injection, was investigated. In 30 patients who underwent spin-echo magnetic resonance (MR) imaging before and